Literature DB >> 29316003

Pathophysiology of severe asthma: We've only just started.

Gregory G King1,2,3, Alan James1,4,5, Louise Harkness1,3, Peter A B Wark1,6,7.   

Abstract

Severe asthma is defined by the high treatment requirements to partly or fully control the clinical manifestations of disease. It remains a problem worldwide with a large burden for individuals and health services. The key to improving targeted treatments, reducing disease burden and improving patient outcomes is a better understanding of the pathophysiology and mechanisms of severe disease. The heterogeneity, complexity and difficulties in undertaking clinical studies in severe asthma remain challenges to achieving better understanding and better outcomes. In this review, we focus on the structural, mechanical and inflammatory abnormalities that are relevant in severe asthma.
© 2018 Asian Pacific Society of Respirology.

Entities:  

Keywords:  airway inflammation; airway remodelling; pathophysiology; severe asthma

Mesh:

Year:  2018        PMID: 29316003     DOI: 10.1111/resp.13251

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  20 in total

Review 1.  Alpha-1 Asthma Overlap Syndrome: a Clinical Overview.

Authors:  Manuel Izquierdo; Himanshu Rawal; Michael Armstrong; Chad R Marion
Journal:  Curr Allergy Asthma Rep       Date:  2022-05-20       Impact factor: 4.919

Review 2.  Modulation of cell signaling pathways by Phyllanthus amarus and its major constituents: potential role in the prevention and treatment of inflammation and cancer.

Authors:  Hemavathy Harikrishnan; Ibrahim Jantan; Akilandeshwari Alagan; Md Areeful Haque
Journal:  Inflammopharmacology       Date:  2019-12-02       Impact factor: 4.473

Review 3.  In Vitro Models for Studying Respiratory Host-Pathogen Interactions.

Authors:  Sarah L Barron; Janire Saez; Róisín M Owens
Journal:  Adv Biol (Weinh)       Date:  2021-05-04

4.  miR-144-3p Is a Biomarker Related to Severe Corticosteroid-Dependent Asthma.

Authors:  José M Rodrigo-Muñoz; Marta Gil-Martínez; Clara Lorente-Sorolla; Raquel García-Latorre; Marcela Valverde-Monge; Santiago Quirce; Joaquín Sastre; Victoria Del Pozo
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

5.  iNOS Inhibition Reduces Lung Mechanical Alterations and Remodeling Induced by Particulate Matter in Mice.

Authors:  Carla Máximo Prado; Renato Fraga Righetti; Fernanda Degobbi Tenorio Quirino Dos Santos Lopes; Edna Aparecida Leick; Fernanda Magalhães Arantes-Costa; Francine Maria de Almeida; Paulo Hilário Nascimento Saldiva; Thais Mauad; Iolanda de Fátima Lopes Calvo Tibério; Mílton de Arruda Martins
Journal:  Pulm Med       Date:  2019-03-11

Review 6.  Microphysiological systems modeling acute respiratory distress syndrome that capture mechanical force-induced injury-inflammation-repair.

Authors:  Hannah Viola; Jonathan Chang; Jocelyn R Grunwell; Louise Hecker; Rabindra Tirouvanziam; James B Grotberg; Shuichi Takayama
Journal:  APL Bioeng       Date:  2019-11-22

7.  FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals.

Authors:  Laurent Portel; Eric Parrat; Cécilia Nocent-Ejnaini; Gilles Mangiapan; Anne Prud'homme; Jean-Philippe Oster; Corinne Aperre de Vecchi; Cyril Maurer; Chantal Raherison; Didier Debieuvre
Journal:  ERJ Open Res       Date:  2019-10-30

Review 8.  Autophagy: A Friend or Foe in Allergic Asthma?

Authors:  Efthymia Theofani; Georgina Xanthou
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

9.  Different effects of acetyl-CoA carboxylase inhibitor TOFA on airway inflammation and airway resistance in a mice model of asthma.

Authors:  Fang-Fang Zhu; Yi-Min Wang; Guang-Zhen He; Yi-Fei Chen; Ya-Dong Gao
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

Review 10.  Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives.

Authors:  Alicia Padilla Galo; Marina Labor; Angelica Tiotiu; Ilaria Baiardini; Nicola Scichilone; Fulvio Braido
Journal:  Patient Relat Outcome Meas       Date:  2018-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.